TNF Pharmaceuticals Inc. Ordinary Shares TNFA 深 滬
等待開盤 08-27 09:30:00 美东时间
0.0779
+0.009
+13.72%
華盛通- 最 高0.093
- 今 開0.0732
- 成交量 1.98亿股
- 最 低 0.0725
- 昨 收 0.0685
- 總市值 110.49万
- 52周最高 1.95
- 市盈率 靜 --
- 換手率 1397.15%
- 52周最低 0.0609
- 委 比 99.72%
- 總股本 1418.41万
- 歷史最高 65664.00
- 量 比 2.44
- 振 幅 29.93%
- 歷史最低 0.0609
- 每 手 1
- 風險率 3.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
Shares of MongoDB, Inc. (NASDAQ:MDB) rose sharply in pre-market trading after t...
今天 18:05
TNF Pharmaceuticals Q2 EPS $(0.18) Up From $(4.54) YoY
TNF Pharmaceuticals (NASDAQ:TNFA) reported quarterly losses of $(0.18) per share. This is a 96.04 percent increase over losses of $(4.54) per share from the same period last year.
08-20 05:54
TNF Pharmaceuticals Improves Its Financial Position Over The Past 5 Months Through A Material Reduction In Liabilities, While Maintaining Total Assets Of Over $17M As Of June 30, 2025
TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that is has
08-20 05:22
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DIH Holding US (NASDAQ:DHAI) shares rose 35.1% to $0.34 during Friday'...
07-19 05:06
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
Shares of Data Storage Corporation (NASDAQ:DTST) rose sharply in pre-market tra...
07-16 18:04
TNF Pharmaceuticals And DADA2 Foundation Launch Compassionate Use Study Of Oral TNF-Alpha Inhibitor Isomyosamine For Rare Pediatric Inflammatory Disease
Study evaluates novel small molecule TNF-alpha inhibitor as potential alternative to biologic treatmentsTNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company
06-24 21:22
TNF Pharmaceuticals Q1 EPS $(0.36) Up From $(5.14) YoY
TNF Pharmaceuticals (NASDAQ:TNFA) reported quarterly losses of $(0.36) per share. This is a 93 percent increase over losses of $(5.14) per share from the same period last year.
05-16 05:55
TNF Pharmaceuticals Amends Bylaws to Alter Voting Rules
TNF Pharmaceuticals ( ($TNFA) ) has shared an update. On May 9, 2025, TNF Pharm...
05-10 05:49
TNF Pharmaceuticals And Renova Health Announce Initial Results From AI-Driven Study Of 30K Patients On GLP-1 Agonists, Highlighting Potential Of Isomyosamine To Improve Diagnosis, Preserve Muscle Mass, And Enhance Treatment For Inflammatory Conditions
Use of AI and machine learning accelerates identification of patient groups whose care can be improvedFirst study examines pro-inflammatory TNF-α levels in patients receiving GLP-1 agonists including Wegovy® or
05-08 21:22
TNF Pharmaceuticals Announces New Board and Shareholder Votes
TNF Pharmaceuticals ( ($TNFA) ) just unveiled an update. At the recent Annual M...
2024-11-26 21:28
